Janus kinase inhibitors for the therapy of atopic dermatitis

The JAK-STAT pathway is involved in the signaling of multiple cytokines driving cutaneous inflammation in atopic dermatitis (AD). Janus kinase (JAK) inhibitors target individual receptor-associated kinases, thereby preventing the mediation of inflammatory signals. Several JAK inhibitors with varying...

Descripción completa

Detalles Bibliográficos
Autores principales: Traidl, Stephan, Freimooser, Sina, Werfel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439108/
https://www.ncbi.nlm.nih.gov/pubmed/34532638
http://dx.doi.org/10.5414/ALX02272E

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439108/
https://www.ncbi.nlm.nih.gov/pubmed/34532638
http://dx.doi.org/10.5414/ALX02272E

Ejemplares similares